RareCyte, Inc.

The 2026 RareCyte Calendar Image Contest is now open! As we invite you to submit your images, let’s take a moment to celebrate last year’s stunning cover winner.   📸 Featured Image: Non-Small Cell Lung Cancer 🔍 Platform: Orion 🧑🔬 Submitted by: Zhihong (Z) Chen, PhD, Human Immune Monitoring Center, OCCAM Immune, Icahn School of Medicine at Mount Sinai Want to be featured in next year’s calendar? Submit your image here: https://lnkd.in/gZS5RUtw #SpatialBiology #RareCyteCalendar

Fast-track your spatial biology programs with our Precision Biology Services!   Our expert team offers comprehensive services utilizing Orion, the only multiplex immunofluorescence platform capable of delivering 20 channels per round. We support your research from custom assay development ➡️ clinical trial testing. Ready to accelerate your spatial biology project? Let's connect! https://lnkd.in/emnpVDc Learn more about our service offerings: https://lnkd.in/ggqsqiH7   #OrionSpatial #SpatialBiology #ClinicalTrials

Easily design a spatial biomarker panel using Orion validated antibody-conjugates. We take the time to validate our antibodies to ensure high-quality results and save you time. ✅   Don’t see the antibody you need? Make use of Orion’s easy-to-use conjugation kit to label your antibody or utilize our custom biomarker reagent development services.   View our full validated biomarker list: https://bit.ly/3AyVNhF #OrionSpatial #SpatialBiology

Say hello to Orion LE, the newest member of the Orion spatial biology family. Orion LE is a multiplex immunofluorescence platform that makes spatial biology accessible for every lab – delivering comprehensive spatial protein profiling and unlocking actionable insights for translational research.   Inquire to learn more: https://lnkd.in/gG_SBfr3 #OrionSpatial #SpatialBiology

Spatial transcriptomics technologies have led to an explosion of candidate biomarkers with potential clinical value. 💥 To determine clinical relevance, those RNA markers need to be validated and tested at the protein level across large sample sets. Read our blog to learn more about moving from spatial transcriptomics to protein profiling: https://lnkd.in/gZ-5tPb4 #OrionSpatial #SpatialBiology #SpatialTranscriptomics #SpatialProteomics

OCCAM Immune and RareCyte, Inc. are partnering to take spatial biology to the next level, combining cutting-edge tech with deep immune expertise to help researchers see tissues like never before. With RareCyte’s Orion™ platform, OCCAM Immune can image up to 18 biomarkers at once on a single tissue section, ending the time-consuming, round-by-round staining. Just fast, clear, high-res data that helps unlock insights into how cells interact in health, disease, and therapy. 📖 Learn how this partnership is accelerating discoveries in cancer, immunology, and precision medicine: https://lnkd.in/eH6keiUT #SpatialBiology #Immunology #DrugDevelopment #MultiplexImaging #CancerResearch #PrecisionMedicine

💡 Translational spatial biology enables you to progress from biomarker discovery to the development of clinically actionable panels that drive impactful patient outcomes. Achieving this requires bridging the gap between spatial transcriptomics and protein analysis: while spatial transcriptomics uncovers a broad spectrum of potential targets, only protein-level validation can truly confirm their biological and clinical relevance. Read the blog below to learn more ⬇️ https://lnkd.in/gZ-5tPb4 #SpatialBiology #OrionSpatial

Excited to share that in this CHS-114 (CCR8) clinical trial, the Orion platform will be leveraged to identify protein biomarkers of drug treatment, response, resistance and/or safety in CHA-114 treated patients. Orion is transforming spatial biology in clinical trials by capturing more biomarkers in a single round, enabling high-quality, high-throughput, multiplexed spatial insights. Congrats to OCCAM Immune and Coherus Oncology for the collaboration! #OrionSpatial #SpatialBiology #ClinicalTrial

Back by popular demand…the RareCyte Calendar Image Contest! 📅 Submissions are now open to be featured in our 2026 calendar.   To enter, submit your most awe-inspiring image taken on either an Orion or CyteFinder instrument. Learn more about the contest: https://lnkd.in/gZS5RUtw #SpatialBiology #LiquidBiopsy #RareCyteCalendar

Ready to upgrade your tissue analysis to the next level? Multiplex immunofluorescence (IF) changes the game by allowing you to detect and quantify multiple biomarkers – simultaneously – within a single tissue section. That means you keep the big picture intact while diving deep into the details.   Want to see it in action? Our interactive multiplex IF data sets offer a detailed look at tissue architecture, heterogeneity, and immune response – all in one seamless experience. ➡️ https://lnkd.in/gBE3pQ5W #SpatialBiology #OrionSpatial